1 min read
Syndax Pharmaceuticals Falls 16.4% in Premarket Trading; SK hynix Down 5.1%
U.S. stock-index futures were mixed as technology shares faced pressure and investors awaited quarterly earnings from major banks.

Syndax Pharmaceuticals dropped 16.4% and SK hynix fell 5.1% in U.S. premarket trading Tuesday as stock-index futures were mixed and technology shares faced pressure.
SK hynix declined 5.1% after falling 4.8% in earlier premarket coverage.
Investors were awaiting quarterly earnings from major banks as technology shares came under pressure before the U.S. market opened.
The update was recorded at 7:16 a.m. ET (11:16 UTC) Tuesday, Oct. 13.